2 Results

People

  1. Gillis
    Gillis
  2. Gordon
    Gordon
  3. Iyer
    Iyer
  4. Lezcano Lopez
    Lezcano Lopez
  5. Markova
    Markova
  6. Weir
    Weir

Groups

  1. Department of Medicine (2)
  2. Dermatology Service (2)
  3. Dermatology (2)
  4. Division of Subspecialty Medicine (2)
  5. Department of Pathology and Laboratory Medicine (1)
  6. Genitourinary Oncology Service (1)
  7. Melanoma Disease Management Team (1)
  8. Solid Tumor Oncology Division (1)
  9. Survivorship Research (1)
  1. "bullous"
Formats
  1. Journal Article (1)
  2. Review (1)
Groups
  1. Department of Medicine (2)
  2. Dermatology (2)
  3. Dermatology Service (2)
  4. Division of Subspecialty Medicine (2)
  5. Department of Pathology and Laboratory Medicine (1)
  6. Genitourinary Oncology Service (1)

More Groups

People
  1. Alina Markova (1)
  2. Allison Gordon (1)
  3. Gopakumar Iyer (1)
  4. Maria Lezcano Lopez (1)
  5. Maura Gillis (1)
  6. Vanessa Weir (1)
Years
  1. 2025 (1)
  2. 2023 (1)
Publications
  1. Biomedicines (1)
  2. JAAD Case Reports (1)
Publishers
  1. Elsevier Inc. (1)
  2. MDPI (1)

Results (2)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Use of dupilumab to manage a grade 3 cutaneous adverse effect from enfortumab vedotin/pembrolizumab treatment in a patient with metastatic urothelial carcinoma
    Journal Article

    Gillis, M. C.; Weir, V. R.; Lezcano, C.; Iyer, G.; Gordon, A.
    JAAD Case Reports (2025)

    Fulltext@MSK | Save
  • A review of bullous dermatologic adverse events associated with anti-cancer therapy
    Review

    Parisi, R.; Shah, H.; Shear, N. H.; Ziv, M.; Markova, A.; Dodiuk-Gad, R. P.
    Biomedicines (2023)

    Fulltext@MSK | Save